| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $96.4M | -31.9% |
| SG&A Expense | $30.8M | -41.9% |
| Operating Income | -$178.4M | +8.3% |
| Interest Expense | $3.9M | -40.0% |
| Net Income | -$179.7M | +8.6% |
| EPS (Basic) | -$1.99 | +10.8% |
| EPS (Diluted) | -$1.99 | +10.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.9M | -93.4% |
| Current Assets | $20.2M | -91.2% |
| Total Assets | $23.1M | -92.7% |
| Current Liabilities | $7.9M | -77.1% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $7.9M | -94.3% |
| Stockholders' Equity | $15.1M | -91.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$150.1M | -3.5% |
| Capital Expenditures | $5.3M | +45.4% |
| Investing Cash Flow | $12.9M | -84.1% |
| Financing Cash Flow | -$75.5M | -138.0% |
| Free Cash Flow | -$155.4M | -4.5% |